Literature DB >> 10771513

Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion.

L Cao1, Y Yao, V Lee, C Kiani, D Spaner, Z Lin, Y Zhang, M E Adams, B B Yang.   

Abstract

Most squamous epithelial cells are strictly anchorage-dependent cell types. We observed that epidermal growth factor (EGF) promoted the growth of A431 squamous carcinoma cells in suspension cultures but suppressed cell growth and induced apoptosis in monolayer cultures, suggesting that loss of adhesion is responsible for the effects observed in monolayer culture, before cell death. Consistent with this finding, we demonstrated that EGF reduced cell attachment, cell-cell interaction, and cell spreading. Treatment with EGF increased cell adhesion-regulated expression of p21 but suppressed expressions of cyclin A, D1, cdk2, and retinoblastoma protein (pRb), leading to cell cycle arrest and adhesion-regulated programmed cell death. To test directly whether promoting cell adhesion could reduce the effects of EGF, we grew cultures on plates coated with type II collagen. On these plates, cell adhesion was enhanced and EGF treatment had little effect on cell adhesion and apoptosis when cells were attached to the collagen. The collagen effects were dose dependent, and cell cycle and cell cycle-associated proteins were altered accordingly. Finally, when cultures were plated on bacterial Petri dishes, which completely disrupted cell attachment to substratum, the level of apoptosis was greatly higher and cell cycle was arrested as compared with monolayer cultures. Taken together, our results strongly suggest that the EGF-induced cell cycle arrest and apoptosis in monolayer cultures was the result of a decline in cell adhesion. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771513

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

1.  Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.

Authors:  Jonathan K Pokorski; Marisa L Hovlid; M G Finn
Journal:  Chembiochem       Date:  2011-09-29       Impact factor: 3.164

2.  Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis.

Authors:  W Yang; W W Du; X Li; A J Yee; B B Yang
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

3.  Epidermal growth factor can optimize a serum-free culture system for bone marrow stem cell proliferation in a miniature pig model.

Authors:  Xuan Wang; Feng Zheng; Ousheng Liu; Shutao Zheng; Yishan Liu; Yuehong Wang; Zhangui Tang; Liangjun Zhong
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-09-04       Impact factor: 2.416

4.  Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species.

Authors:  M C Chang; B J Uang; H L Wu; J J Lee; L J Hahn; J H Jeng
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells.

Authors:  Jane C J Chao; Wen Li Peng; Sheng-Hsuan Chen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

6.  Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2.

Authors:  William W Du; Weining Yang; Elizabeth Liu; Zhenguo Yang; Preet Dhaliwal; Burton B Yang
Journal:  Nucleic Acids Res       Date:  2016-02-09       Impact factor: 16.971

7.  Tumor Growth Suppression and Enhanced Radioresponse by an Exogenous Epidermal Growth Factor in Mouse Xenograft Models with A431 Cells.

Authors:  Yu Jin Lim; Sang-Rok Jeon; Jae Moon Koh; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2015-01-07       Impact factor: 4.679

8.  Ergosterol peroxide activates Foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells.

Authors:  Xiangmin Li; Qingping Wu; Ming Bu; Liming Hu; William W Du; Chunwei Jiao; Honghui Pan; Mouna Sdiri; Nan Wu; Yizhen Xie; Burton B Yang
Journal:  Oncotarget       Date:  2016-06-07

9.  A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells.

Authors:  XinTian Zhang; Jun Meng; Zhao-Yi Wang
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

Review 10.  Novel human antibody therapeutics: the age of the Umabs.

Authors:  Sigrid R Ruuls; Jeroen J Lammerts van Bueren; Jan G J van de Winkel; Paul W H I Parren
Journal:  Biotechnol J       Date:  2008-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.